摘要
目的观察思连康联合谓葆在小儿肠系膜淋巴结炎临床治疗中的具体应用效果。方法回顾性分析2011年1月～2013年1月我院收治的经高频彩超确诊的肠系膜淋巴结炎80例患儿,分为实验组(思连康联合谓葆治疗)40例和对照组(抗炎药物口服治疗)40例,比较两组肠系膜淋巴结炎患儿的具体临床疗效。结果实验组总有效率为95%,治愈率80.0%;对照组总有效率为77.5%,治愈率为50.0%;实验组效果更明显(P<0.05)。结论对肠系膜淋巴结炎患儿实施思连康、谓葆联合治疗,效果显著且无药物毒副反应,值得推广。
Objective To observe the concrete application effect of siliankang joint weibao in the treatment of pediatric mesenteric lymphadenitis. Methods 80 cases of pediatric mesenteric lymphadenitis definited by the high frequency color Doppler ultrasound in our hospital from January 2011 to January 2013 were retrospectively analyzed,and divided into experiment group（40 cases, siliankang joint weibao therapy） and control group （40 cases,oral anti-inflammatory drugs treatment）,specific clinical curative effect of two groups were compared. Results The total effective rate of experiment group was 95%, the cure rate 80.0%; the total effective rate of control group was 77.5%,the cure rate 77.5%;the effect of experiment group was more obvious（P 〈 0.05）. Conclusion The effect of siliankang joint weibao in the treatment of pediatric mesenteric lymphadenitis is obvious and worthy of promotion,without adverse drug reactions.
出处
《中国医药科学》
2013年第13期63-64,共2页
China Medicine And Pharmacy
关键词
思连康
谓葆
小儿肠系膜淋巴结炎
Siliankang
Weibao
Pediatric mesenteric lymphadenitis
